Voichita Bar Ad, MD

Contact Dr. Bar Ad

111 South 11th Street
Room G-302, Bodine Center
Philadelphia, PA 19107

(215) 955-5936
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma
  2. A Pilot Study of Radiation Therapy in Combination with Pembrolizumab in Patients with Metastatic Renal Cell Cancer
  3. Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment
  4. Disparity in age at lung cancer diagnosis between current and former smokers
  5. Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas
  6. A nomogram to determine required seed air kerma strength in planar 131Cesium permanent seed implant brachytherapy
  7. Combining radiation and immune checkpoint blockade in the treatment of head and neck squamous cell carcinoma
  8. Carotid dosimetry after re-irradiation with 131Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
  9. Single institution implementation of permanent 131Cs interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma
  10. Phase iib, randomized, double-blind trial of GC4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer
  11. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
  12. Dual Modality Implant for Simultaneous Magnetic Nanoparticle Heating and Brachytherapy Treatment of Tumor Resection Cavities in Brain
  13. AJCC-8ed nodal staging does not predict outcomes in surgically managed HPV-associated oropharyngeal cancer
  14. Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment (Journal of Neuro-Oncology, (2018), 137, 1, (171-177), 10.1007/s11060-017-2709-0)
  15. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment
  16. A systematic review of treating recurrent head and neck cancer: A reintroduction of brachytherapy with or without surgery
  17. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma
  18. Increasing faculty participation in resident education and providing cost-effective self-assessment module credit to faculty through resident-generated didactics
  19. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer
  20. Immune biomarkers of treatment failure for a patient on a phase i clinical trial of pembrolizumab plus radiotherapy